Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment

被引:1034
作者
Dai, Yunlu [1 ,2 ]
Xu, Can [2 ]
Sun, Xiaolian [1 ]
Chen, Xiaoyuan [2 ]
机构
[1] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Ctr Mol Imaging & Translat Med, Xiangan South Rd, Xiamen 361102, Peoples R China
[2] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院; 中国国家自然科学基金;
关键词
MESOPOROUS SILICA NANOPARTICLES; INTERSTITIAL FLUID PRESSURE; ENDOTHELIAL GROWTH-FACTOR; TARGETED DRUG-DELIVERY; CANCER-ASSOCIATED FIBROBLASTS; NEAR-INFRARED LIGHT; KILLER T-CELLS; BREAST-CANCER; PHOTODYNAMIC THERAPY; EXTRACELLULAR-MATRIX;
D O I
10.1039/c6cs00592f
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Nanovehicles can efficiently carry and deliver anticancer agents to tumour sites. Compared with normal tissue, the tumour microenvironment has some unique properties, such as vascular abnormalities, hypoxia and acidic pH. There are many types of cells, including tumour cells, macrophages, immune and fibroblast cells, fed by defective blood vessels in the solid tumour. Exploiting the tumour microenvironment can benefit the design of nanoparticles for enhanced therapeutic effectiveness. In this review article, we summarized the recent progress in various nanoformulations for cancer therapy, with a special emphasis on tumour microenvironment stimuli-responsive ones. Numerous tumour microenvironment modulation strategies with promising cancer therapeutic efficacy have also been highlighted. Future challenges and opportunities of design consideration are also discussed in detail. We believe that these tumour microenvironment modulation strategies offer a good chance for the practical translation of nanoparticle formulas into clinic.
引用
收藏
页码:3830 / 3852
页数:23
相关论文
共 290 条
[1]
VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor [J].
Abakumov, MaximA. ;
Nukolova, Natalia V. ;
Sokolsky-Papkov, Marina ;
Shein, Sergey A. ;
Sandalova, Tatiana O. ;
Vishwasrao, Hemant M. ;
Grinenko, Nadezhda F. ;
Gubsky, Iliya L. ;
Abakumov, Artem M. ;
Kabanov, Alexander V. ;
Chekhonin, Vladimir P. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (04) :825-833
[2]
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
[3]
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
[4]
AdvancesLiu H. M. Rsc, 2015, RSC ADV, V5, P20848
[5]
The tumour microenvironment as a target for chemoprevention [J].
Albini, Adriana ;
Sporn, Michael B. .
NATURE REVIEWS CANCER, 2007, 7 (02) :139-147
[6]
Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[7]
The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine [J].
Alshamsan, Aws ;
Hamdy, Samar ;
Samuel, John ;
El-Kadi, Ayman O. S. ;
Lavasanifar, Afsaneh ;
Uludag, Hasan .
BIOMATERIALS, 2010, 31 (06) :1420-1428
[8]
Neutrophil Function: From Mechanisms to Disease [J].
Amulic, Borko ;
Cazalet, Christel ;
Hayes, Garret L. ;
Metzler, Kathleen D. ;
Zychlinsky, Arturo .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30, 2012, 30 :459-489
[9]
Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, James M. ;
Shive, Matthew S. .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 :72-82
[10]
Development of Novel Tumor-Targeted Theranostic Nanoparticles Activated by Membrane-Type Matrix Metalloproteinases for Combined Cancer Magnetic Resonance Imaging and Therapy [J].
Ansari, Celina ;
Tikhomirov, Grigory A. ;
Hong, Su Hyun ;
Falconer, Robert A. ;
Loadman, Paul M. ;
Gill, Jason H. ;
Castaneda, Rosalinda ;
Hazard, Florette K. ;
Tong, Ling ;
Lenkov, Olga D. ;
Felsher, Dean W. ;
Rao, Jianghong ;
Daldrup-Link, Heike E. .
SMALL, 2014, 10 (03) :566-575